We describe a 29-year-old female who presented with rhabdomyolysis shortly after starting a course of sodium valproate. A thorough investigation revealed a likely mitochondrial origin inducing this susceptibility. An underlying mitochondrial disorder should be considered in all patients who present with undifferentiated disease whilst taking sodium valproate.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073682 | PMC |
| http://dx.doi.org/10.1159/000447087 | DOI Listing |
Publication Analysis
Top Keywords
sodium valproate
12
valproate exacerbating
4
exacerbating underlying
4
underlying disorder
4
disorder fatty
4
fatty acid
4
acid metabolism
4
metabolism describe
4
describe 29-year-old
4
29-year-old female
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!